De Burlo Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,320
| Closed | -$503K | – | 90 |
|
|
2023
Q1 | $503K | Buy |
12,320
+13
| +0.1% | +$530 | 0.1% | 78 |
|
|
2022
Q4 | $631K | Hold |
12,307
| – | – | 0.14% | 65 |
|
|
2022
Q3 | $539K | Buy |
12,307
+3,267
| +36% | +$143K | 0.13% | 66 |
|
|
2022
Q2 | $474K | Sell |
9,040
-3,967
| -30% | -$208K | 0.14% | 41 |
|
|
2022
Q1 | $673K | Sell |
13,007
-256,700
| -95% | -$13.3M | 0.13% | 67 |
|
|
2021
Q4 | $15.9M | Buy |
269,707
+164,700
| +157% | +$9.73M | 2.31% | 13 |
|
|
2021
Q3 | $4.52M | Buy |
+105,007
| New | +$4.52M | 0.73% | 42 |
|
|
2020
Q1 | – | Sell |
-5,486
| Closed | -$204K | – | 80 |
|
|
2019
Q4 | $204K | Buy |
+5,486
| New | +$204K | 0.04% | 81 |
|
|
2019
Q3 | – | Sell |
-5,486
| Closed | -$225K | – | 89 |
|
|
2019
Q2 | $225K | Hold |
5,486
| – | – | 0.04% | 82 |
|
|
2019
Q1 | $221K | Sell |
5,486
-791
| -13% | -$31.9K | 0.04% | 91 |
|
|
2018
Q4 | $259K | Buy |
6,277
+51
| +0.8% | +$2.1K | 0.06% | 87 |
|
|
2018
Q3 | $260K | Hold |
6,226
| – | – | 0.05% | 106 |
|
|
2018
Q2 | $214K | Hold |
6,226
| – | – | 0.05% | 103 |
|
|
2018
Q1 | $209K | Hold |
6,226
| – | – | 0.05% | 100 |
|
|
2017
Q4 | $213K | Sell |
6,226
-1,107
| -15% | -$37.9K | 0.04% | 103 |
|
|
2017
Q3 | $248K | Hold |
7,333
| – | – | 0.06% | 102 |
|
|
2017
Q2 | $233K | Buy |
7,333
+2,899
| +65% | +$92.1K | 0.05% | 99 |
|
|
2017
Q1 | $143K | Buy |
+4,434
| New | +$143K | 0.03% | 99 |
|
|
2014
Q2 | – | Sell |
-6,595
| Closed | -$201K | – | 107 |
|
|
2014
Q1 | $201K | Buy |
+6,595
| New | +$201K | 0.05% | 93 |
|